SMT19969: Completed Phase II enrollment

Summit completed enrollment of 100 patients in the double-blind, North American Phase II CoDIFy trial comparing 200 mg oral SMT19969 twice daily for 10 days vs. 125 mg oral vancomycin given 4 times a ...